Clinical Trial Update: Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing Surgery [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating defined green tea catechin extract in localized prostate cancer patients undergoing surgery was terminated. The update does …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Defined Green Tea Catechin Extract (epigallocatechin gallate (EGCG))

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Stage I Prostate Cancer, Stage IIA Prostate Cancer | Phase 2 | Status: TERMINATED